|
|
Multiple Myeloma
|
|
Multiple Myeloma
[an error occurred while processing this directive]
POST OF THE DAY 24 Nov 2005
The bull case is that Velcade is on the cusp of considerable use in a first line settings for two very difficult diseases - Multiple Myeloma and Mantle Cell ...
- Motley Fool
GlycoGenesys, Inc. Comments on 2005 Third Quarter Financial ... 24 Nov 2005
In addition, GCS-100LE is being evaluated in a Phase I/II trial for multiple myeloma at the Dana-Farber Cancer Institute in Boston, Massachusetts and Roswell ...
- Genetic Engineering News,
White officers misidentified Young's father 24 Nov 2005
...wheelchair. He suffers from multiple myeloma -- cancer of the bone marrow -- that has left him partially paralyzed from the waist down. ...
- Providence Journal (subscription),
The Rev. James 'Al' Smith, pastor 24 Nov 2005
...pastor of Sweet Union Baptist Church in West Philadelphia and a retired Inquirer editorial assistant, died of complications from multiple myeloma Saturday at ...
- Philadelphia Inquirer,
Fever of Unknown Origin May Be a Marker for Undiagnosed Cancer 24 Nov 2005
Fever of unknown origin was most strongly associated with Hodgkin’s and non-Hodgkin’s lymphomas, sarcomas, leukemia, multiple myeloma, and cancers of the ...
- Cancer Consultants (press release),
Are safety labeling and safety warnings enough? 24 Nov 2005
...malformations. Interestingly enough, it recently returned to the market as Thalomid and is used to treat leprosy and multiple myeloma. ...
- Naples Sun Times,
The Secret Origins of AIDS: Facts, Fallacies & Conspiracy Theories 24 Nov 2005
...decade indicate this virus is clearly associated with rapidly-fatal cancers of the lung (mesothelioma), bone marrow cancer (multiple myeloma), brain tumours in ...
- Mathaba.Net,
Multiple myeloma: NPI-0052, a compound from marine bacteria ... Nov 19, 2005
...derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and ...
- Xagena.it,
Callisto Anti-Cancer Drug Atiprimod Selected for Oral Presentation ... Nov 22, 2005
...and other serious healthcare threats, today announced that its first human clinical trial of its new anti-cancer drug Atiprimod in multiple myeloma patients is ...
- Genetic Engineering News,
Nancy Sumberaz Named President of Multiple Myeloma Research ... Oct 27, 2005
27 /PRNewswire/ -- The Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC) announced today that Nancy Sumberaz, a ...
- Yahoo! News (press release)
XOMA Reports Third Quarter 2005 Financial Results; Highlights ... Nov 2, 2005
...profitability.". -- Chiron Corporation (Nasdaq: CHIR) and XOMA commenced Phase I clinical testing of CHIR-12.12 in multiple myeloma subjects. ...
- Genetic Engineering News,
GlycoGenesys Initiates Additional Prestigious Medical Site for GCS ... Nov 17, 2005
Park Cancer Institute, (RPCI) Buffalo, New York as a clinical site for its Phase I/II dose escalation trial in patients with multiple myeloma, the second most ...
- Genetic Engineering News,
New Data from Investigational Study of QUADRAMET in Multiple ... Nov 16, 2005
Synergistic Activity of the Proteasome Inhibitor PS-341 with Non-Myeloablative 153-Sm-EDTMP in a Syngeneic, Orthotopic Model of Multiple Myeloma" (A. Goel, A ...
- PharmaLive.com (press release),
ZIOPHARM Oncology Announces ZIO-101 Data Published in Blood Nov 21, 2005
...-- Abstract 5163: "In vitro activity of a novel organic arsenical (S-dimethylarsino-glutathione, ZIO-101) against multiple myeloma," by Lawrence Boise, Ph.D ...
- Business Wire (press release),
Nancy Sumberaz Named President of Multiple Myeloma Research ... Oct 27, 2005
...- Former Pharmaceutical Executive Joins Growing Non-Profit Focused On Accelerating Drug Discovery for Multiple Myeloma - NEW CANAAN, Conn., Oct. ...
- PR Newswire (press release),
Nancy Sumberaz Named President of Multiple Myeloma Research ... Oct 27, 2005
NEW CANAAN, Conn., October 27, 2005 /PRNewswire/ -- The Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC ...
- PharmaLive.com (press release),
Celgene Receives Approvable Letter From FDA for THALOMID(R) in ... Nov 15, 2005
Nasdaq: CELG) today announced the US Food and Drug Administration (FDA) issued an approvable letter in response to the Company's sNDA for multiple myeloma (MM ...
- PR Newswire (press release),
Seasons resident succumbs to cancer Nov 17, 2005
When Mary Travis was diagnosed last year with multiple myeloma, her neighbors and friends in The Seasons off Marvin Road organized fundraisers to help with the ...
- The Olympian,
The International Myeloma Foundation Gala Expected to Raise $400 ... Nov 10, 2005
Myeloma, also called multiple myeloma, is a bone marrow cancer that affects blood cell production causing fatigue, weakness, and pain. ...
- PR Newswire (press release),
Celgene Receives Approvable Letter From FDA for THALOMID(R) in ... Nov 15, 2005
CELG - News) today announced the US Food and Drug Administration (FDA) issued an approvable letter in response to the Company's sNDA for multiple myeloma (MM). ...
- Yahoo! News (press release)
FDA Sends Second Approvable Letter For Celgene's Thalomid Nov 15, 2005
By Aaron Lorenzo. Celgene Corp.'s Thalomid (thalidomide) again is approvable for multiple myeloma, but only after certain conditions are met, the FDA said. ...
- BioWorld Online (subscription),
PharmaMar Presents Pharmacogenomic Data on Yondelis(R) at CTOS Nov 22, 2005
It also features Aplidin(R), in Phase II, designated Orphan Drug for acute lymphoblastic leukaemia and for multiple myeloma; as well as Kahalalide F in Phase II ...
- PR Newswire UK (press release),
Fulfilling a mother's last wish Nov 22, 2005
...officer. Now that could actually happen. Maria was diagnosed 14 months ago with multiple myeloma, an incurable form of cancer. It ...
- Arizona Republic,
5 kids to get green cards, fill mother's final wish Nov 22, 2005
...children are now limitless. Carrillo was diagnosed 14 months ago with multiple myeloma, an incurable form of cancer. She shared her ...
- Arizona Daily Star,
CuraGen and TopoTarget Announce Updated PXD101 Phase I Results ... Nov 18, 2005
...program for PXD101 also includes three proof-of-concept trials evaluating this HDAC inhibitor as a potential treatment for multiple myeloma, colorectal, and ...
- Yahoo! News (press release)
THE HARTFORD COURANT Nov 1, 2005
It has been nine years since Kathy Giusti was diagnosed with multiple myeloma, an incurable form of blood cancer with one of the lowest five-year survival ...
- NorthJersey.com,
NBC Nightly News Anchor Brian Williams Presented With MMRF ... Oct 30, 2005
30 /PRNewswire/ -- The Multiple Myeloma Research Foundation (MMRF) presented NBC Nightly News anchor Brian Williams with the MMRF Leadership Award at the 9th ...
- PR Newswire (press release),
Health Notes Nov 17, 2005
2841. Multiple Myeloma Group meets monthly to discuss experiences, emotions and challenges of living with multiple myeloma. The ...
- Burke Connection,
UPDATE 1-Celgene gets approvable letter for myeloma drug Nov 15, 2005
O: Quote, Profile, Research) on Tuesday said it is closer to gaining US regulatory approval for its Thalomid drug for the treatment of multiple myeloma, if the ...
- Reuters
Memorial employees keep stem cells on ice Nov 20, 2005
...were kept viable were leftovers from the stem-cell donation that saved Noreen Duhon's life 2 ½ years ago when she was treated for multiple myeloma, a cancer ...
- Times Picayune,
NBC Nightly News Anchor Brian Williams Presented With MMRF ... Oct 31, 2005
NEW CANAAN, Conn., October 30, 2005 /PRNewswire/ -- The Multiple Myeloma Research Foundation (MMRF) presented NBC Nightly News anchor Brian Williams with the ...
- PharmaLive.com (press release),
NJ business briefs Nov 16, 2005
...said US regulators asked for more information before they will approve expanding the use of the drug Thalomid to treat multiple myeloma, a type of blood cancer ...
- NorthJersey.com,
Krieser, Joyce E. Nov 21, 2005
Bay Ave., Oconto Falls, died Saturday morning, November 19, 2005, with her family by her side, following a six-year illness with multiple myeloma (bone cancer ...
- Green Bay Press Gazette,
DJ Swing appeal Nov 9, 2005
Now, eighteen months after being diagnosed with multiple myeloma, a rare cancer of the bone marrow, DJ Swing needs donors to come forward if he is to have a ...
- Black Information Link,
Rare blood disease target of fundraiser Nov 3, 2005
Those attending can expect to be wined, dined and entertained, with proceeds donated to the International Myeloma Foundation and Pittsburgh Multiple Myeloma. ...
- Pittsburgh Post Gazette,
Celgene Thalomid 'Approvable' for Cancer Nov 15, 2005
...on Tuesday said the Food and Drug Administration issued the company an "approvable letter" to expand the use of Thalomid for the treatment of multiple myeloma. ...
- Forbes
UPDATE 2-FDA requests more information on cancer drug Nov 15, 2005
...(CELG.O: Quote, Profile, Research) on Tuesday said US regulators won't approve its drug Thalomid as a treatment for multiple myeloma until the company provides ...
- Reuters
FDA Wants More Data From Celgene Nov 15, 2005
Though Thalomid is FDA-approved specifically for treating leprosy, the majority of prescriptions for the drug are written for multiple myeloma, a progressive ...
- TheStreet.com
MOZOBIL(TM) abstracts accepted for presentation at the American ... Nov 15, 2005
...is a standard medical procedure used to restore the immune system of patients who have had chemotherapy to treat cancers, such as multiple myeloma and non ...
- PR Newswire (press release),
Bortezomib for salvage therapy against progressive myeloma Oct 26, 2005
Despite the initial efficacy of these therapies against multiple myeloma (MM), relapse is invariably the rule. Bortezomib (Velcade ...
- MedIndia,
ImmunoGen, Inc. Reports First Quarter Fiscal Year 2006 Financial ... Nov 3, 2005
...huC242-DM4 into clinical testing and initiated a third study with our huN901-DM1 - a study to assess the compound for use in the treatment of multiple myeloma. ...
- Genetic Engineering News,
(PRN) - CounterPath Announces Proposed Offering of Convertible ... Nov 16, 2005
...[+]. (PRN) - New Data from Investigational Study of QUADRAMET(R) in Multiple Myeloma to be Presented at American Society of Hematology Annual Meeting ... [+. ...
- Bolsamania.com,
MethylGene Reports Interim Clinical Results for MGCD0103 Nov 15, 2005
...in pancreatic and lung cancer models in vivo, and the synergistic anticancer activity of MGCD0103 with interferon alpha in multiple myeloma cell lines. ...
- CCNMatthews (Communiqués de presse),
Celgene gets approvable letter for myeloma drug Nov 15, 2005
Research) on Tuesday said it has received an approvable letter from the US Food and Drug Administration for Thalomid in the treatment of multiple myeloma. ...
- Reuters
ImmunoGen, Inc. Announces Presentation of HuN901-DM1 Clinical Data ... Nov 16, 2005
...to target and kill CD56-expressing cancer cells and is in clinical testing for the treatment of SCLC, other CD56-positive solid tumors, and multiple myeloma. ...
- Genetic Engineering News,
Gentium Reports Third Quarter Financial Results; Provides ... Nov 15, 2005
..."Finally, very encouraging pre-clinical data using Defibrotide to treat refractory multiple myeloma led to planning an independent Phase I/II study at ten ...
- PharmaLive.com (press release),
Addition of Genasense® to Dacarbazine Improves Outcomes in ... Nov 16, 2005
Genasense is a Bcl-2 antisense oligodeoxynucleotide that is being evaluated for the treatment of multiple myeloma, acute myeloid leukemia and acute lymphoid ...
- Cancer Consultants (press release),
(PRN) - Media Alert: Ultimate Software Presents Free Webcast ... ... Nov 15, 2005
MD ... [+. PRN) - The International Myeloma Foundation Advocates Formal Approval of Thalomid(R) for Multiple Myeloma ... [+. PRN ...
- Bolsamania.com,
Field lab health compensation delayed, denied Nov 13, 2005
...lab from 1955 to 1967. He died in 1998 at age 62 from multiple myeloma, or cancer of the plasma cells. Over the years, Roesch used ...
- Los Angeles Daily News,
Researchers to Present Positive Phase I Study Results for ... Nov 16, 2005
Studies already underway in pancreas cancer, malignant melanoma, multiple myeloma, lung, breast and prostate cancer are enrolling rapidly and will lead to a ...
- Genetic Engineering News,
North Texas' Top Blood Cancer Specialists to Speak at The Leukemia ... Nov 9, 2005
...presented by top blood cancer specialists in North Texas, as well as breakout sessions on disease-specific topics: leukemia, lymphoma and multiple myeloma. ...
- Yahoo! News (press release)
Millennium Announces Clinical Updates at Analyst Day Meeting Nov 2, 2005
Millennium reported key clinical advancements in the development of VELCADE® (bortezomib) for Injection, its market-leading drug in relapsed multiple myeloma. ...
- Yahoo! News (press release)
Plumas County news on-line Nov 15, 2005
6, 2005, at the age of 64. She had survived a stem-cell transplant treating multiple myeloma five years ago with courage and strength. ...
- Plumas County Newspapers,
Former area woman running to fight cancer Nov 18, 2005
Her father-in-law, Gary Gilmore, of Bloomfield, is currently battling multiple myeloma - a rare blood disease in which abnormal plasma cells build up in the ...
- Linton Daily Citizen,
Denosumab, shows increased bone mineral density, Amgen Nov 18, 2005
...its potential in a broad range of bone loss conditions including osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma and rheumatoid ...
- Medical News Today (press release),
Biotech Field Shows New Life Nov 18, 2005
One hot biotech company, Celgene, (CELG) is working on a treatment for multiple myeloma and myelodysplastic syndrome — diseases whose obscurity puts them on ...
- Investor's Business Daily (subscription)
Reduced-Intensity Allogeneic Stem Cell Transplants with ... Nov 16, 2005
...acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), acute lymphocytic leukemia (ALL), multiple myeloma (MM) and ...
- Cancer Consultants (press release),
NY actress and Carnegie native pulls benefit show together Oct 26, 2005
...on Saturday, Nov. 5, at 9:30 pm to benefit Multiple Myeloma, a cancer of plasma cells which attacks and destroys bone. The event ...
- Gateway Newspapers
Callisto Pharmaceuticals to Profile Key Drug Development ... Nov 3, 2005
..."We have made important strides in moving forward with our drugs in development for currently incurable blood cancers such as multiple myeloma and relapsed ...
- PharmaLive.com (press release),
Structure of the Hematological Cancer Market and Its Perspectives Nov 3, 2005
...and Competition to their offering. Blood cancers include leukemia, lymphoma, and multiple myeloma. Collectively, these cancers are ...
- Business Wire (press release),
Millennium Pharmaceuticals Shares Appear Fairly Valued Nov 3, 2005
2006 we believe investors need to gain confidence that Velcade will weather Revlimid's competition well and continue to grow in multiple myeloma, that Velcade ...
- Forbes
Why We Can't Prevent Cancer Nov 4, 2005
...pancreas, prostate, rectum, soft tissues (soft tissue sarcoma), skin, stomach, testicles, and thyroid, plus leukemia, mesothelioma, and multiple myeloma. ...
- CounterPunch,
Living Loudly: He was an active, strong house builder with a ... Oct 26, 2005
Before being diagnosed with multiple myeloma, Nicholas Baldukas was a large, very strong man who spent his days building houses and playing tennis three times ...
- Journal Times Online,
Greene, East draw inspiration from each other Nov 11, 2005
...mile walk on Oct. 16 to benefit the Multiple Myeloma Research Foundation, with more than 500 people participating. It was an effort ...
- phillyBurbs.com,
Rare cancer blamed on fuel solvents Oct 28, 2005
Sometimes he wore a protective mask, sometimes not. Two years ago Zwarts was diagnosed with multiple myeloma, a rare and incurable blood cancer. ...
- Stuff.co.nz,
Resveratrol Combats Bone Marrow Cancer, Alzheimer’s Disease Nov 4, 2005
1 issue of Cancer Research (65:9943-52, 2005), the first study investigated the effects of resveratrol on multiple myeloma--accumulations of malignant plasma ...
- Natural Products Industry Insider,
PacMab to raise $5m to develop drug Oct 27, 2005
...cKap. cKap is being developed to treat multiple myeloma, an incurable cancer of the blood affecting around 2,500 Australians. The ...
- Sydney Morning Herald (subscription),
Callisto's Drug Development Achievements to be Spotlighted at ... Nov 2, 2005
..."Callisto's current drug development programs include Atiprimod, a new treatment for the blood cancer multiple myeloma, and L-Annamycin, a drug designed to ...
- Business Wire (press release),
Millennium Reports Strong Third Quarter 2005 Financial Results Oct 26, 2005
...for VELCADE compared to the higher level of spending in 2004 associated with the preparation of the sNDA filing for VELCADE in the multiple myeloma second-line ...
- Yahoo! News (press release)
Promising Data From Phase I Trial of Exelixis' XL880 Presented at ... Nov 15, 2005
...of Met has been documented as a negative prognostic indicator in patients with various carcinomas, and in patients with multiple myeloma, glioma and other ...
- PR Newswire (press release),
REVLIMID(R) Marketing Authorization Application Accepted by EMEA ... Oct 26, 2005
MDS. REVLIMID also has been designated as an Orphan Medicinal Product in the EU for the treatment of multiple myeloma (MM). Celgene ...
- PR Newswire (press release),
Celgene Corporation Reports Strong Operating, Regulatory and ... Nov 3, 2005
...of Hematology 47th Annual Meeting in Atlanta (December 9-13, 2005) - REVLIMID First Peer-Reviewed Publication on Newly Diagnosed Multiple Myeloma in Journal ...
- PR Newswire (press release),
Millennium Maps Out Cost-Cuts Oct 27, 2005
Velcade is approved by the Food and Drug Administration for the blood cancer multiple myeloma when the disease has returned after a previous treatment. ...
- TheStreet.com
Indian River County news in brief: November 10 Nov 10, 2005
...concert is free and a love offering will be taken to benefit Pastor Jerry West, youth minister of New Hope Ministries, who is battling multiple myeloma, a rare ...
- Vero Beach Press-Journal (subscription),
FDA Mails “Approvable Letter� for Celgene’s Thalomid Nov 15, 2005
...has received an “approvable letter� from the Food and Drug Administration to expand the use of Thalomid for the treatment of multiple myeloma, a cancer of ...
- Business New Jersey (subscription),
Charles Page’s 9-year battle with cancer ends at age 66 Nov 1, 2005
Since being diagnosed in 1996 with multiple myeloma -- cancer that develops in the blood -- Page struggled to the pulpit for as many Sunday mornings as he ...
- BP News,
(PRN) - Eclipsys to Present at Credit Suisse First Boston ... Nov 15, 2005
...[+]. (PRN) - Celgene Receives Approvable Letter From FDA for THALOMID(R) in Treatment of Newly Diagnosed Multiple Myeloma ... [+. ...
- Bolsamania.com,
Appeal to get drug comes too late Nov 11, 2005
...age of 42. by colleagues at Worksop Fire Station, lost his brave battle after developing multiple myeloma in May. Robin was diagnosed ...
- Worksop Guardian,
Glad You Asked: Kiwanis Club's holiday ornament; more on how to ... Nov 8, 2005
...cell phone. * Racine Area Multiple Myeloma Support Group: The RAMMSG has collected more than 2,000 cell phones in two years. Monies ...
- Journal Times Online,
North Palm Beach County community clubs: November 13 Nov 11, 2005
Babysitting is free at the meetings. For information, call Janell Averett at (561) 575-9573. • Multiple Myeloma Support Group meets at 11:30 am on the fourth ...
- Jupiter Courier (subscription),
AnorMED reports fiscal 2006 second quarter results, and progress ... Nov 8, 2005
To date, 98 non-Hodgkin's lymphoma (NHL) patients and 100 multiple myeloma (MM) patients have entered into the Phase III trials. ...
- PR Newswire (press release),
'She just loved kids' Nov 9, 2005
...friends gathered around her bedside. She was diagnosed in July 2004 with multiple myeloma, a rare blood cancer. Parker, who moved to ...
- Windsor Tribune,
Researchers Achieve Rapid Restoration of Immunity in Immune ... Oct 25, 2005
Society's Specialized Center of Research and Director of Translational Research at Penn's Abramson Cancer Center, was focused on multiple myeloma patients and ...
- Medical News Today (press release),
Centers for Medicare and Medicaid Services Encourages Use of NCCN ... Nov 8, 2005
Patients, the Journal of the National Comprehensive Cancer Network (JNCCN), Cancer Resource Lines for Leukemia and Multiple Myeloma, educational conferences ...
- Business Wire (press release),
Cytogen Reports Third Quarter 2005 Financial Results Nov 2, 2005
QUADRAMET is Cytogen's flagship product for the relief of pain due to metastatic bone disease arising from prostate, breast, multiple myeloma and other types ...
- PR Newswire (press release),
See's been county's 'constant' Oct 27, 2005
Unfortunately, neither has an incurable form of cancer known as multiple myeloma, a cancer of the stem cells in a person's bone marrow affecting an estimated ...
- Portage Daily Register,
Drug could make a motza Oct 27, 2005
IIa trial. CKap is being developed to treat multiple myeloma, an incurable blood cancer which affects around 2500 Australians. So ...
- Australian,
Davis and the band of hopeless Nov 13, 2005
...cancer gold, ovarian cancer dark green, “chemical injury awareness� entwined mauve and yellow, spaying and neutering cats brown, multiple myeloma dark red ...
- Times Online,
John Hennessy | Bank executive, 64 Nov 15, 2005
64, of West Chester, a retired bank executive who had fought to save benefits for terminated coworkers in the early 1990s, died of multiple myeloma Tuesday at ...
- Philadelphia Inquirer,
Unveaten Giants claim baseball title Nov 9, 2005
Chris Adkins was the overall men's winner, and Betsy Bulat won the women's title at the Multiple Myeloma Research Foundation's Race for Research 5K. ...
- Atlanta Journal Constitution (subscription),
Stem cell surgery at Command Hospital Nov 10, 2005
Usha Devi, wife of a serving JCO in the Army, had difficulty in passing urine and stool and was diagnosed with advanced multiple myeloma, which is a type of ...
- Pune Newsline,
Blair worked as UE instructor, and later became a pastor Nov 9, 2005
Glenn Blair, 79, died Tuesday at Binghamton General Hospital. He had multiple myeloma cancer, his wife said. After becoming a minister in 1980, The Rev. ...
- Press & Sun-Bulletin,
Well-known NC pastor dies Oct 31, 2005
1991, died Oct. 28 following a nine-year battle with multiple myeloma, a form of cancer that affects the blood. Page is survived ...
- Raleigh Biblical Recorder,
Happy at home Nov 4, 2005
In December 2004, Hinde was diagnosed with a rare form of cancer, multiple myeloma - rare because it only affects about 12,000 people a year, according to the ...
- North Platte Telegraph,
Two-Year Trial Results of Amgen Investigational Therapy for Bone ... Nov 13, 2005
...potential in a broadrange of bone loss conditions including osteoporosis,treatment-induced bone loss, bone metastases, multiple myeloma andrheumatoid arthritis ...
- Finanzen.net,
Chiron Reports Third-Quarter 2005 Adjusted Earnings of $0.38 per ... Oct 25, 2005
The Phase I trial is for patients with multiple myeloma, a type of cancer that is associated with expression of the CD40 antigen on the cancer cell surface. ...
- Genetic Engineering News,
Cytogen Announces Presentation of Data from Phase II Study ... 03 Oct 2005
Skeletal invasion by prostate, breast, multiple myeloma, and other cancers often creates an imbalance between the normal process of bone destruction and ...
- PR Newswire (press release)
Charity champ set to take plunge 03 Oct 2005
...charity. Mr Turley, 49, from, Eaton, was diagnosed with multiple myeloma, a form of cancer which affects the blood in July 2004. ...
- Norwich Evening News
Melphalan/Prednisone Favorable in Multiple Myeloma Patients ... Sep 30, 2005
Alkeran®) plus the steroid prednisone appears to be favorable to dexamethasone-based therapies among newly diagnosed patients with multiple myeloma who are ...
- Cancer Consultants (press release)
Obese women face greater multiple myeloma risk Sep 27, 2005
Health) - The results of a new prospective study provide additional evidence that obesity may increase women's risk of developing multiple myeloma, a type of ...
- Reuters.uk
Multiple Myeloma Survival Linked with Circulating Plasma Cells Sep 26, 2005
Multiple myeloma patients with fewer circulating plasma cells appear to survive longer than patients with more circulating plasma cells, according to a study ...
- Cancer Consultants (press release)
Revlimid®/Dexamethasone Effective Initial Therapy for Multiple ... Sep 21, 2005
...combination consisting of Revlimid (lenalidomide) and the steroid dexamethasone is an effective option for the treatment of newly diagnosed multiple myeloma. ...
- Cancer Consultants (press release)
Revlimid® and Dexamethasone Highly Active in Newly Diagnosed ... Sep 23, 2005
Researchers from the Mayo Clinic have reported a very high response rate for patients with multiple myeloma receiving induction therapy with Revlimid ...
- Cancer Consultants (press release)
Circulating Plasma Cells Predict Survival in Multiple Myeloma Sep 20, 2005
...have reported that the quantity of circulating plasma cells is an independent predictive factor for survival in patients with newly diagnosed multiple myeloma. ...
- Cancer Consultants (press release)
Doctor rides for cancer research Oct 2, 2005
Dr. Abonour. "I'm the first Mexican that he worked on and he's done a good job; I'm in remission (from multiple myeloma)". About ...
- Marion Chronicle Tribune
Combo therapy breakthrough for multiple myeloma Sep 2, 2005
...combination therapy with lenalidomide (Revlimid â„¢ ) and dexamethasone (combination is called Rev/Dex) looks like a breakthrough treatment for multiple myeloma ...
- myDNA.com
MRI of Bone Marrow Predicts Outcomes of Multiple Myeloma Sep 6, 2005
...article published in the Annals of Oncology, results from magnetic resonance imaging (MRI) of bone marrow in patients with untreated multiple myeloma helps to ...
- Cancer Consultants (press release)
Multiple myeloma, Revlimid and Dexamethasone show promise Sep 3, 2005
Cancer Center demonstrated that combination therapy with Lenalidomide ( Revlimid ) and Dexamethasone looks like a breakthrough treatment for multiple myeloma. ...
- Xagena.it
Cancer doctor rides for patients Sep 30, 2005
The cancer specialist will travel more than 120 miles in two days to raise money for the research of multiple myeloma, a cancer of the plasma cell that affects ...
- Marion Chronicle Tribune
Turning A Death Sentence To Life Sep 27, 2005
It has been nine years since Kathy Giusti was diagnosed with multiple myeloma, an incurable form of blood cancer with one of the lowest five-year survival ...
- Hartford Courant
Pain reliever stops multiple myeloma cancer Aug 31, 2005
...cyclooxygenase-2 (COX-2). The study showed that the drug dimethyl-celecoxib (DMC) halts tumor growth even in drug-resistant lines of multiple myeloma cells. ...
- Cancerfacts.com
UPDATE 2-Celgene expects Revlimid trial to resume quickly Sep 28, 2005
Celgene confirmed a published report that the Phase III trial, involving patients recently diagnosed with multiple myeloma, had been suspended after some ...
- Reuters
Three New Cancer Centers Join Multiple Myeloma Research Consortium Sep 8, 2005
Vincent's Comprehensive Cancer Center Join Forces With Existing MMRC Members to Accelerate Drug Development for Multiple Myeloma --. ...
- PharmaLive.com (press release)
Contribute to help find cure for multiple myelomaPublished ... Sep 28, 2005
In 2003, my husband, Larry D. Roberts, was diagnosed with multiple myeloma, a rare cancer of the bone marrow. This cancer remains ...
- Elkhart Truth
Preclinical cancer drug data reveals MM efficacy Sep 19, 2005
GlycoGenesys', GCS-100, targets Galectin-3 in multiple myeloma cells in vitro. Multiple myeloma is a bone marrow cancer in which ...
- Drug Researcher.com
New Mechanistic Frame Work For GlycoGenesys' Cancer Drug Candidate ... Sep 19, 2005
...cancer drug candidate GCS-100 has been shown to bind to Galectin-3. Galectin-3 is over-expressed in a variety of cancers including multiple myeloma, as well as ...
- dBusinessNews Boston (press release)
Gentium SpA meldt introductie van onafhankelijke fase I/II-studie ... Sep 21, 2005
...( BW)(GENTIUM-SPA)(GNT) Gentium SpA Announces Initiation of Independent Phase I/II Study of Defibrotide to treat Multiple Myeloma Business Editors/Health ...
- Netherlands Corporate News
Gentium SpA Announces Initiation of Independent Phase I/II Study ... Sep 21, 2005
...the "Company") announced today that its lead product, Defibrotide, will be the subject of an independent Phase I/II study to treat Multiple Myeloma (MM) in ...
- Business Wire (press release)
I'm Just Fine; Thanks for Asking Oct 2, 2005
I am doing miraculously fine. Today is my ninth anniversary with multiple myeloma, which is bone marrow cancer. I still have active disease. ...
- Hartford Courant
Celgene halts drug trial over blood clot fears Sep 29, 2005
Wednesday. The independent trial, which has 250 participants so far, is testing Revlimid's effectiveness against multiple myeloma. ...
- NorthJersey.com
ImmunoGen, Inc. Initiates Clinical Testing of HuN901-DM1 for ... Sep 7, 2005
IMGN) today announced the initiation of clinical testing with its Tumor-Activated Prodrug (TAP) compound, huN901-DM1, for the treatment of multiple myeloma. ...
- Business Wire (press release)
Oncologist Running Across Indiana to Bring Hope to Patients with ... Sep 18, 2005
...will run and cycle the more than 120 miles between Indianapolis and Fort Wayne in an effort to raise awareness and funding to study multiple myeloma, a rare ...
- Medical News Today (press release)
Drug AMD-3100 may help cancer patients who need stem cell ... Sep 19, 2005
In the phase II trial, researchers were attempting to determine if patients with multiple myeloma or non-Hodgkin's lymphoma who received the drug AMD-3100 ...
- News-Medical.net
Celgene cancer drug clinical trial suspended - WSJ Sep 27, 2005
The trial of 250 patients examines Revlimid's effectiveness, in combination with a steroid, in patients with multiple myeloma, a cancer of the plasma cells in ...
- Reuters
Doctor’s biathlon for cancer research Sep 26, 2005
By William Miller. In 1998 I was diagnosed with multiple myeloma, a rare blood cancer. I have had two stem-cell transplants and well ...
- Fort Wayne Journal Gazette
Cell-based therapy of heart, lung and blood disease funded Sep 29, 2005
Treatment trials of stem cell therapies for individuals with hematologic cancers such as lymphoma, Hodgkin's disease and multiple myeloma will be the initial ...
- myDNA.com
Celgene Cancer Drug Clinical Trial Suspended -- WSJ Sep 28, 2005
The trial of 250 patients is examining Revlimid's effectiveness, in combination with a steroid, in patients with multiple myeloma. ...
- Cancerpage.com
Nyack walk to raise money to fight blood cancer Sep 30, 2005
Her brother died of leukemia as a child and one of her good friends has been battling multiple myeloma for six years. "It's a beautiful night," Numeroff said. ...
- The Journal News.com
Bone Protecting Drugs Reduce Pain and Fractures in Metastatic ... Sep 29, 2005
The bone-protecting medications are already in common used among patients with osteoporosis and multiple myeloma, a cancer that affects bone marrow. ...
- eMaxHealth.com
Doctor there for his patients -- heart, body and soul Sep 29, 2005
Such concern is admirable by any standard, but Abonour will take his dedication to patients and his determination to find a cure for multiple myeloma to a new ...
- Indianapolis Star
Revlimid Trial Stopped: Report Sep 28, 2005
The trial was looking at how well the drug worked, when combined with a steroid, in fighting a type of cancer called multiple myeloma, according to the report. ...
- TheStreet.com
Local Cancer-Survivor Priest to Climb Mt. Kilimanjaro to Raise ... Sep 15, 2005
Foundation (IMF). Father Phil was diagnosed with multiple myeloma, a cancer of the plasma cells of the bone, in March 2001. "I hope ...
- Business Wire (press release)
CuraGen and TopoTarget Initiate Phase Ib Clinical Trial with ... Sep 27, 2005
...agents. PXD101 is currently being evaluated in a Phase II open-label clinical trial for the treatment of advanced multiple myeloma. ...
- PharmaLive.com (press release)
Remember Thalidomide? Sep 14, 2005
But the real goal for Celgene is FDA approval of Revlimid to treat a more common form of blood cancer called multiple myeloma, which is diagnosed in about ...
- Smartmoney.com (subscription)
Playing defense with health care funds Sep 28, 2005
He owns Celgene, which has a drug to treat multiple myeloma, a form of blood cancer, and Sepracor, whose approved insomnia treatment has the potential to be a ...
- International Herald Tribune
Eye On Stocks For Wednesday, Sept. 28 Sep 27, 2005
The company will now spearhead research of the experimental drug for the potential treatment of non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma ...
- Forbes
Barbour Wants To Rebuild Bigger, Better Sep 28, 2005
Saint Louis oyster fisherman Glenn Strong $14 million in damages after finding chemicals from the plant responsible for causing his multiple myeloma, a rare ...
- Jackson Channel.com
Cytokinetics and GlaxoSmithKline Amend Collaboration Agreement for ... Sep 27, 2005
...activities to explore the potential application of SB-743921 for the treatment of non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma, subject to ...
- PharmaLive.com (press release)
Trial of Celgene cancer drug halted Sep 28, 2005
The trial of 250 patients examines Revlimid's effectiveness -- in combination with a steroid -- in patients with multiple myeloma, a cancer of the plasma cells ...
- United Press International
Envionrmental agency reports no leaks at DuPont Sep 27, 2005
Louis oyster fisherman Glenn Strong $14 million in damages after finding chemicals from the plant responsible for causing Strong's multiple myeloma, a rare ...
- Biloxi Sun Herald
INNOVIVE Pharmaceuticals Announces Scientific Advisory Board ... Sep 27, 2005
He was instrumental in bringing to clinical study, Velcade, the first of a new class of medicines approved for treatment of multiple myeloma. ...
- Business Wire (press release)
In a Jewish Manhattan milieu. Sep 26, 2005
...failure. Jake was in remission from multiple myeloma; Jenny was going in for a triple bypass; Phil had a second heart attack. Fred ...
- Philadelphia Inquirer
'Light the Night' celebration in Reston to benefit cancer patients Sep 28, 2005
...we were finally adjusting to life with our 2- and 3-year-old daughters when my oncologist called with the news that I had been diagnosed with multiple myeloma. ...
- TimesCommunity.com
Name to remember - David Pavkovich Sep 26, 2005
...into the medical field. I worked in his lab at Northwestern - he works with a disease called multiple myeloma. I truly admire him ...
- Munster Times
Grandparenting has many benefits Sep 26, 2005
...health. Cindy Giallombardo was struggling with painful multiple myeloma (plasmas cell cancer) when her first grandchild Kyle was born. ...
- Rutland Herald
Football: East overpowers West Sep 22, 2005
Playing their third regular-season game without head coach Larry Greene, who is continuing treatments for multiple myeloma, the Patriots received a first ...
- Doylestown Patriot
Chernin wins prestigious award Sep 26, 2005
...much been my life until 2004 when suddenly and without much notice my mom became very ill and a few months later we learned that my dad had multiple myeloma. ...
- Camrose Canadian
The art of healing Sep 27, 2005
Army Medical Center the past 10 years - as Gail Pfister underwent chemotherapy, stem cell transplants and radiation treatments for multiple myeloma, a cancer ...
- AZ Central.com
New Preclinical Discovery Shows GlycoGenesys' Cancer Drug ... Sep 19, 2005
In addition, GCS-100LE is being evaluated in a Phase I/II trial for multiple myeloma at the Dana-Farber Cancer Institute in Boston, Massachusetts and the Lucy ...
- Genetic Engineering News
Movers & Shakers Sep 7, 2005
Mass., developer of anti-cancer drugs, said it would conduct clinical testing with its Tumor-Activated Prodrug compound, huN901-DM1, to treat multiple myeloma. ...
- MarketWatch
US advisers back Celgene blood disorder drug Sep 14, 2005
...often remembered for tragic birth defects when used as a sedative in pregnant women but now finding new uses, such as for the blood cancer multiple myeloma. ...
- Reuters.uk
GlycoGenesys, Inc. Achieves Primary Objective in Phase I Trial in ... Sep 8, 2005
These toxicities are common limitations of several current treatments for patients with multiple myeloma and CLL. A Phase I/II study ...
- PharmaLive.com (press release)
Celecoxib able to control chemotherapy resistant tumor cells Aug 30, 2005
Nonetheless, the scientists showed that the analog manages to halt tumor growth even in drug-resistant lines of multiple myeloma cells. ...
- RxPG NEWS
AnorMED Release: Medical journal, Blood, reports new stem cell ... Sep 6, 2005
...stem cell transplantation: one study will enroll 300 patients with non-Hodgkins lymphoma and the other study will enroll 300 patients with multiple myeloma. ...
- Hype & Hope
Callisto CEO Dr. Gary Jacob to Present Breakthrough Anti-Cancer ... Sep 1, 2005
...with Callisto's developing anti-cancer drugs, including Annamycin for relapsed acute leukemias and Atiprimod to treat relapsed or refractory multiple myeloma. ...
- PharmaLive.com (press release)
Celebrex Analog Fights Cancer Aug 30, 2005
A new study suggests that a chemical relation to Pfizer’s COX-2 inhibitor could become a treatment for multiple myeloma. Researchers ...
- Red Herring
FDA Advisory Panel Backs an Anemia Drug Sep 14, 2005
Although it is approved to treat a complication of leprosy, Thalomid is mainly used off-label for multiple myeloma, a bone marrow cancer. ...
- New York Times
STEM CELL RESEARCH: University of Michigan Sep 20, 2005
2007. It has assembled a large library of these drugs to test in patients with multiple myeloma, breast cancer and colon cancer. ...
- Detroit Free Press
COVER STORY: How Michiganders are aiding stem cell research Sep 20, 2005
You'll read about: New cancer drugs at the University of Michigan. They'll soon be tested on patients with multiple myeloma, a cancer of the bone marrow. ...
- Detroit Free Press
Forum: Blood cancer is too often ignored Sep 18, 2005
The local pharmaceutical industry also announced the introduction of new drugs treating multiple myeloma, another progressive blood disease, at the forum. ...
- Xinhua
New warning for colorectal cancer drug Sep 15, 2005
...caused decades ago. In recent years thalidomide has proved effective against another blood cancer, multiple myeloma. Researchers do ...
- MSNBC
The Week Ahead: Sept. 12-16 Sep 9, 2005
For Chief Executive John Jackson, who has built Celgene on a related drug, Thalomid, for the blood cancer multiple myeloma, the drug represents a big chance to ...
- Forbes
FDA panel backs Celgene's cancer drug; shares gain Sep 14, 2005
Revlimid by Oct. 7. The company has also been testing the drug to treat the cancer multiple myeloma. Analysts at Morgan Stanley ...
- Investor's Business Daily (subscription)
Genta's CLL Data Better; Don't Count Them Out' Sep 19, 2005
Genasense also has been tried against advanced multiple myeloma but failed last year, sending Genta's stock down 23 percent to $1.27 and causing at least one ...
- BioWorld Online (subscription)
Jones Co. jury deadlocks on punitive damages in DuPont lawsuit Sep 23, 2005
Strong's cancer. Strong had sued DuPont, claiming dioxins from DuPont triggered his multiple myeloma, a rare blood cancer. Strong's ...
- Dateline Alabama
Steinmark winner's funeral today Sep 24, 2005
Mr. Kersey's family had found a bone marrow match - he suffered from multiple myeloma - and he had been scheduled for a transplant in mid-October. ...
- Rocky Mountain News
Judge declares mistrial in DuPont lawsuit Sep 23, 2005
A four-firm legal team sued the chemical giant, on behalf of Strong, who claimed dioxins from DuPont triggered his multiple myeloma, a rare blood cancer. ...
- SunHerald.com
John Bevan Ford dies Sep 19, 2005
Friday, aged 75. For years Mr Ford had suffered from multiple myeloma, an incurable but treatable cancer of the bone cells. A number ...
- Manawatu Standard
YMCA not just a place to pump some iron Sep 20, 2005
...“I had multiple myeloma, which is a bone marrow cancer, but I have been in complete remission since 2001 and have been doing very well,� Hunter said. ...
- Edison/Metuchen Sentinel
Gilda had her own way; now Village has Gilda’s Way Sep 22, 2005
...event. Rosanne Kalick, who co-chairs the White Plains club’s group for multiple myeloma, a very rare cancer, is a longtime member. ...
- The Villager
Alice Simmons a caring, compassionate teacher Sep 19, 2005
1998. She was a fifth-grade teacher at Pleasant Hill Elementary from 2000 until she was diagnosed with multiple myeloma in 2003. ...
- Cincinnati Enquirer
Michael deCourcy Hinds, Reporter, Dies at 58 Sep 22, 2005
Manhattan. He was 58 and a Manhattan resident. The cause was complications of multiple myeloma, said his wife, Susan Lapinski. Mr ...
- New York Times
The Book on GlycoGenesys Sep 23, 2005
...article appearing in the medical journal Cancer Research explained how GCS-100 could also prove to be an effective therapy in treating multiple myeloma, a blood ...
- Smartmoney.com (subscription)
Cancer Research Fund allocates nearly $2m. to local scientists Sep 20, 2005
Alzheimer's. This discovery led to the development of Velcade, a drug used to treat multiple myeloma, a cancer of the bone marrow. ...
- Jerusalem Post
Scintigraphy scan may help clinicians properly diagnose and then ... Sep 21, 2005
...amyloidosis, which is often hereditary, and acquired monoclonal immunoglobulin light-chain amyloidosis, which is often a consequence of multiple myeloma. ...
- News-Medical.net
APLIDIN(R) COMMENCES COMBINATION Sep 14, 2005
Aplidin(R), in Phase II, designated Orphan Drug for acute lymphoblastic leukaemia by the EC in 2003 and by the FDA in 2004, and for multiple myeloma by the FDA ...
- ITNews
The Wellness Community - Greater Boston offers free cancer support ... Sep 15, 2005
16, 12:15-2:15 pm RSVP. Multiple Myeloma Networking: (for adults with multiple myeloma and caregivers): Saturday, Sept. 17, from 10 am to noon. ...
- Wellesley Townsman
Bone marrow drive can help dentist, other African Americans Sep 8, 2005
...in need. The 51-year-old African American dentist was diagnosed with non-Hodgkin's lymphoma and multiple myeloma in 2002. After ...
- Chicago Defender
Celebrex variant attacks tumor cells Aug 31, 2005
...research, published in the journal Blood, shows that a relative of Celebrex was able to inhibit growth in cancer cells, most notably multiple myeloma cells, a ...
- myDNA.com
Health calendar Sep 4, 2005
...(714) 540-5606. maria_clure@yahoo.com. Multiple myeloma support group LA/OC 10:15 am-12:15 pm third Saturday. Joslyn Center, 339 Sheldon St., El Segundo. ...
- OCRegister (subscription)
MedImmune to Acquire Cellective Therapeutics, Inc. Sep 14, 2005
...targeting these antigens may block B-cell activities that are associated with many tumors and autoimmune diseases, including multiple myeloma, B-cell lymphomas ...
- PR Newswire (press release)
Raleigh cancer patient will be there, OSU's treat Sep 10, 2005
State's varsity as a tight end. Downing, 68, suffers from multiple myeloma, a rare bone marrow cancer. Two stem-cell transplants and ...
- News & Observer
FDA Oncologic Drugs Advisory Committee Recommends REVLIMID for ... Sep 14, 2005
Celgene continues to evaluate treatments with REVLIMID for a broad range of hematology and oncology conditions, including; multiple myeloma, the malignant ...
- PharmaLive.com (press release)
FDA Panel to Mull Revlimid Safety Sep 13, 2005
Now the drug is widely used in an off-label setting as a treatment for multiple myeloma, a blood cancer, despite only being approved for leprosy. ...
- TheStreet.com
US FDA staff raise issues with Celgene drug Sep 12, 2005
Revlimid is a newer version of thalidomide, which is approved for treating leprosy but is most often prescribed for treating the blood cancer multiple myeloma. ...
- Reuters
Celgene halted for FDA vote Sep 14, 2005
The company already markets a version of thalidomide called Thalomid, for the treatment of leprosy, and Alkeran, a treatment for the cancer multiple myeloma. ...
- MarketWatch
Celgene Gets FDA Panel Support Sep 14, 2005
Thalidomide has been used in an off-label setting as a treatment for multiple myeloma, a blood cancer, despite only being approved for leprosy.
- TheStreet.com
US advisers back Celgene blood disorder drug Sep 14, 2005
Revlimid to be safer and with fewer side effects than thalidomide, a leprosy drug that is also showing promise in treating the blood cancer multiple myeloma. ...
- Reuters
Celgene May Outgrow Peers Sep 14, 2005
...abnormality. "We assume approval of Revlimid in this indication, as well as in 2006 for multiple myeloma," S&P Equity Research said. ...
- Forbes
Jacob Marinsky isolated promethium ions Sep 9, 2005
1 at his home in Buffalo, where he taught at the State University of New York. He was 87. The cause was multiple myeloma, his family said. ...
- Indianapolis Star
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Multiple Myeloma
you may want to try searching the Internet using the Google search box below.
|
|
|
